UltraGene Ebola: Multiplex qPCR for Outbreak Preparedness
https://www.einpresswire.com/article/915738686/ultragene-ebola-multiplex-qpcr-for-outbreak-preparedness
UltraGene Ebola: Multiplex qPCR for Outbreak Preparedness Read More »
ABL Diagnostics Advances NGS for CMV Resistance Monitoring at SEIMC 2026
https://www.einpresswire.com/article/914346495/abl-diagnostics-advances-ngs-for-cmv-resistance-monitoring-at-seimc-2026
ABL Diagnostics Advances NGS for CMV Resistance Monitoring at SEIMC 2026 Read More »
ABL Diagnostics et le CHRU Nancy : premier bilan positif pour le projet PREDAVIR après 6 mois
https://www.einpresswire.com/article/914324401/abl-diagnostics-et-le-chru-nancy-premier-bilan-positif-pour-le-projet-predavir-apr-s-6-mois
ABL Diagnostics Drives EMEA Expansion with VELA Diagnostics Partnership
https://www.einpresswire.com/article/913871100/abl-diagnostics-drives-emea-expansion-with-vela-diagnostics-partnership
ABL Diagnostics Drives EMEA Expansion with VELA Diagnostics Partnership Read More »
ABL Diagnostics Unveils Next-Generation HIV Genotyping Innovation with the Industry’s Broadest Portfolio
https://www.einpresswire.com/article/913010661/abl-diagnostics-unveils-next-generation-hiv-genotyping-innovation-with-the-industry-s-broadest-portfolio
ICAR 2026 – Persistent APOBEC activity in children with longstanding HIV infection: characterization and correlation with clinical outcome
https://www.abldiagnostics.com/wp-content/uploads/2026/05/P190.pdf
ABL Diagnostics Announces Strategic AI Roadmap to Advance Molecular Research and Global Data Security
https://www.einpresswire.com/article/912523931/abl-diagnostics-announces-strategic-ai-roadmap-to-advance-molecular-research-and-global-data-security
ABL Diagnostics Webinar Series
Official Presentation of the DeepChek® HPV Messenger RNA Genotyping Assay Webinar from June 26, 11h00 CET / Paris time https://ablsa-my.sharepoint.com/:f:/p/matthieu_barralon/EoLXon5w0g9AhQlr5kZTO_gBQ9TVE9AcQJuJu_Cw_9Y1Jw?e=OU2KLh
ABL Diagnostics Webinar Series Read More »
Molecular detection of hrHPV-induced high-grade squamous intraepithelial lesions of the cervix through a targeted RNA next generation sequencing assay
Julia Faillace Thiesen , Elise Jacquemet , Pascal Campagne, Denis Chatelain, Etienne Brochot, Yves‑Edouard Herpe , Nolwenn M. Dheilly , Fabrice Bouilloux, Bénédicte Rognon, Alexandre Douablin, Guillaume Leboucher , Florent Percher, Marc Eloit and Philippe Pérot Abstract Background Cervical cancer screening programs are increasingly relying on sensitive molecular approaches as primary tests to detect high‑risk
ABL Diagnostics Signs Exclusive Distribution Agreement with Riken Genesis to Expand Microbiology Genotyping in Japan
ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, is pleased to announce an exclusive distribution agreement with Riken Genesis Co., Ltd. (https://www.rikengenesis.jp/en.html). Under this partnership, Riken Genesis will promote and commercialize ABLD’s DeepChek® and UltraGene molecular assays across laboratories in Japan, further strengthening its diagnostics portfolio. Through this collaboration, Riken Genesis